PitchSend

Investor Presentaiton

5 ScinoPharm at a Glance ■ ScinoPharm specializes in high potency (steroid/cytotoxic) APIs and injectable provider, serving customers worldwide ■Facility & offices established in Taiwan and expanding in China with a new GMP plant in Changshu & marketing base in Shanghai ■73 generic APIs in current portfolio with 25 APIs launched; 56 US DMFs filed (767 DMFS WW), 33 US DMFs in oncology APIs. 100+ NCE CRAM projects, with 6 NDAs launched and 4 in phase III ■Fully compliant with world-class cGMPs and international regulatory requirements; Certified by US FDA, EMA, EDQM, Australia TGA, Japan PMDA, Korea KFDA, Mexico COFEPRIS and Germany regulatory Authority ScinoPharm

View entire presentation